Tess Oral Paste

Product Overview

Tess Oral Paste is a corticosteroid medication containing Triamcinolone Acetonide as its active ingredient. Designed specifically for oral application, this therapeutic paste effectively treats inflammatory conditions within the oral cavity. Its targeted formulation provides localized relief for mucosal lesions, making it particularly effective for managing mouth ulcers, oral lichen planus, and other inflammatory oral conditions. Packaged in an easy-to-use tube, Tess Oral Paste is commonly prescribed by dental and medical professionals for its anti-inflammatory properties.

Uses

Tess Oral Paste is clinically indicated for the management of inflammatory oral conditions including:
• Recurrent aphthous ulcers (canker sores)
• Oral lichen planus
• Inflammatory mucosal lesions
• Other corticosteroid-responsive oral disorders
The paste exerts potent anti-inflammatory and immunosuppressive effects, effectively reducing pain, swelling, and discomfort associated with these conditions. Patients should strictly adhere to their healthcare provider’s instructions regarding application frequency and duration of treatment.

How to Use

For optimal results:
1. Clean and dry the affected oral area before application
2. Dispense a pea-sized amount onto a clean fingertip
3. Apply a thin layer directly to the lesion
4. Gently dab (do not rub) until evenly distributed
5. Avoid eating or drinking for 30 minutes post-application
Typical dosing frequency ranges from 2-4 applications daily, or as directed by your healthcare provider. Do not exceed prescribed usage.

Mechanism of Action

The therapeutic efficacy of Tess Oral Paste stems from its active component, Triamcinolone Acetonide. This synthetic glucocorticoid:
• Inhibits phospholipase A2 activity
• Reduces prostaglandin and leukotriene synthesis
• Suppresses inflammatory cell migration
• Stabilizes lysosomal membranes
This multi-faceted action effectively controls the inflammatory cascade, providing symptomatic relief while promoting tissue healing.

Dosage and Administration

Dosing should be individualized based on:
• Condition severity
• Lesion size and location
• Patient response
Standard protocol involves applying a thin layer (approximately 0.5cm) to affected areas 2-4 times daily. Treatment duration typically ranges from 3-7 days, though chronic conditions may require extended therapy under medical supervision.

Therapeutic Benefits

Tess Oral Paste offers multiple clinical advantages:
• Targeted drug delivery to oral lesions
• Rapid symptom relief (pain, inflammation)
• Convenient topical application
• Minimal systemic absorption
• Improved patient compliance
The paste formulation ensures prolonged mucosal contact, enhancing therapeutic effectiveness while minimizing potential adverse effects.

Potential Adverse Effects

While generally well-tolerated, some patients may experience:
• Transient burning at application site
• Altered taste perception
• Localized mucosal dryness
• Rare cases of secondary candidiasis
These effects are typically mild and self-limiting. Persistent symptoms warrant medical evaluation.

Precautions

Important safety considerations:
• Contraindicated in fungal/viral oral infections
• Use cautiously in diabetic patients
• Avoid ocular contact
• Not for long-term unsupervised use
• Pregnancy/lactation: Use only if clearly needed
Patients should disclose all current medications and medical history to their prescribing clinician.

Storage Guidelines

Maintain product integrity by:
• Storing at 15-30°C
• Protecting from excessive moisture
• Keeping tube tightly sealed
• Avoiding freezing
• Storing out of children’s reach
Proper storage ensures stability throughout the shelf life.

Medical Disclaimer

This information serves educational purposes only and does not constitute medical advice. While we strive for accuracy, this content cannot replace professional medical judgment. Always consult your healthcare provider regarding:
• Appropriate use
• Potential drug interactions
• Complete safety information
• Individual treatment plans
Our goal is to supplement, not substitute, the crucial patient-provider relationship.